Laboserve is accelerating its global growth

Laboserve is proud to announce that has recently received GMP Certification from the Greek National Medicines Organization (EOF) which is also a member of Mutual Recognition Agreement between FDA and EU, that allows drug inspectors to rely upon information from inspections conducted within each other’s borders.

This is another success towards realization of our growth plan. Apart testing and release accreditation received last year, with the present certification Laboserve now has the green light for GMP manufacturing of oral solutions for clinical and commercial use in all EU countries, as well as other countries following European GMP guidelines.